Prodrugs of 2',3'-didehydro-3'-deoxythymidine. 1993

T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
Faculty of Pharmaceutical Science, Josai University, Saitama, Japan.

Six ester prodrugs of 2',3'-didehydro-3'-deoxythymidine (D4T) were synthesized, and their physicochemical properties were evaluated. Marked differences were observed. All of the prodrugs were chemically stable within the pH range 2-7. Hydrolysis of these esters was observed in all cases for four rat enzyme systems (plasma, liver, duodenum, and kidney), with D4T being regenerated. D4T or the prodrug was administered orally to rats, and the plasma concentrations of D4T and a corresponding prodrug were measured. The half-life of D4T after intravenous administration was 35.9 min. The half-life calculated from the terminal phase and the maximum concentration in plasma following oral administration of D4T were 35.9 min and 48.4 microM, respectively. After oral prodrug administration (with water or olive oil as a solvent), though none of the prodrugs was detected in plasma except for 5'-hemisuccinyl D4T and 5'-hemiglutaryl D4T with olive oil as a solvent, retention time of plasma D4T concentration was extended and the elevated D4T concentration in plasma decreased.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004386 Duodenum The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers. Duodenums
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.

Related Publications

T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
March 1994, Journal of pharmaceutical sciences,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
January 1999, Drug metabolism and disposition: the biological fate of chemicals,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
June 1995, Antiviral research,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
May 2000, Acta crystallographica. Section C, Crystal structure communications,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
January 2004, Nucleosides, nucleotides & nucleic acids,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
June 1996, Antimicrobial agents and chemotherapy,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
December 1995, Antimicrobial agents and chemotherapy,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
September 1996, Biological & pharmaceutical bulletin,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
January 1990, Drug metabolism and disposition: the biological fate of chemicals,
T Hasegawa, and T Seki, and K Juni, and M Saneyoshi, and T Kawaguchi
July 1999, Bioorganicheskaia khimiia,
Copied contents to your clipboard!